We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Berries Found to Protect Brain From Age-Related Damage

By Biotechdaily staff writers
Posted on 29 Aug 2006
As older persons face retirement, many are consuming foods rich in antioxidants, hoping to slow the decrease in function that typically occurs with aging. More...
New research shows that they may be on the right path to better health.

In a U.S. Agricultural Research Service-(ARS; Washington, DC, USA)-funded study, laboratory animals that were fed berry extracts--and then treated to accelerate the aging process--were protected from damage to brain function, the researchers report. ARS is the U.S. Department of Agriculture's (USDA) chief scientific research agency.

Psychologist Dr. Barbara Shukitt-Hale, neuroscientist James Joseph and psychologist Amanda Carey of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (Boston, MA, USA) conducted the study in collaboration with colleagues at the University of Maryland-Baltimore County (USA). The study was published online in August 2006 of the journal Neurobiology of Aging.

Three groups--20 rats in each--were evaluated for approximately three months. The control group was fed a conventional diet of grain-based chow. A second group was given chow with blueberry extract equal to one cup daily in humans. A third group was fed chow with strawberry extract equal to one pint daily in humans. After two months on the diets, half of the rats in each group were treated to trigger the typical losses in learning and motor skills that often come with aging.

Compared to the aged control rats, the aged-but-supplemented rats were much better able to locate--and in some cases remember--the location of an underwater platform. Furthermore, the aged control rats had lower levels of dopamine release than the nonaged control rats. However, these decreases in dopamine release were not seen in the strawberry and blueberry supplemented groups, whether aged or not.

The study findings add to an array of studies performed during the past eight years showing reduced, or in some cases reversed, declines in brain function among rats whose diets were supplemented with either blueberry, cranberry, or strawberry extracts or Concord grape juice.



Related Links:
U.S. Agricultural Research Service

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Manual Pipetting Aid
Pipette Controllers macro
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.